Abstract
The use of aluminum-containing adjuvants originated in 1926 with the observations of Glenny et al. (1926) that an alum-precipitated diphtheria vaccine had greater antigenic properties than the standard diphtheria vaccine. Other aluminum hydroxide gels used in the preparation of vaccines were shown by the early X-ray diffraction and electron microscopy studies of Souza Santos et al. (1958) to consist of crystalline phases ranging from poorly ordered boehmite (aluminum oxyhydroxide, A100H) to well-crystallized gibbsite and bayerite [aluminum hydroxide polymorphs, Al(OH)3]. Aluminum hydroxide gels containing phosphate were also developed as adjuvants. Although aluminum compounds have a long history of use as adjuvants, inconsistent antibody production has been a recurrent problem (Warren and Chedid, 1988). The adjuvant action of aluminum hydroxide has been reviewed by Aprile and Wardlaw (1966), Edelman (1980), Warren et al. (1986), and Nicklas (1992). Although the mechanism of adjuvant action of aluminum hydroxide and related phases is not fully understood, it is likely that surface area, surface charge, and morphology of the aluminum hydroxide are important factors (Hem and White, 1984).
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Al-Shakhshir, R. H., Lee, A. L., White, J. L., and Hem, S. L., 1995a, Interactions in model vaccines composed of mixtures of aluminum-containing adjuvants, J. Colloid Interface Sci. 169:197–203.
Al-Shakhshir, R. H., Regnier, F. E., White, J. L., and Hem, S. L., 1995b, Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminum-containing adjuvants, Vaccine 13:41–44.
Al-Shakhshir, R., Regnier, F., White, J. L., and Hem, S. L., 1994, Effect of protein adsorption on the surface charge characteristics of aluminum-containing adjuvants, Vaccine 12:472–474.
Aprile, M. A., and Wardlaw, A. C., 1966, Aluminum compounds as adjuvants for vaccines and toxoids in man: A review, Can. J. Public Health 57:343–354.
Bleam, W. F., Pfeffer, P. E., Goldberg, S., Taylor, R. W., and Dudley, R., 1991, A 31P solid-state nuclear magnetic resonance study of phosphate adsorption at the boehmite/aqueous solution interface, Langmuir 7:1703–1712.
Callahan, P. M., Shorter, A. L., and Hem, S. L., 1991, The importance of surface charge in the optimization of antigen-adjuvant interactions, Pharm. Res. 8:851–858.
Cheung, T. T. P., Willcox, K. W., McDaniel, M. P., and Johnson, M. M., 1986, The structure of coprecipitated alumino-phosphate catalyst supports, J. Catal. 10:10–20.
Edelman, R., 1980, Vaccine adjuvants, Rev. Infect. Dis. 2:370–383.
Fripiat, J. J., Bosmans, H., and Rouxhet, P. G., 1967, Proton mobility in solids. I. Hydrogenic vibration modes and proton delocalization in boehmite, J. Phys. Chem. 71:1097–1112.
Glenny, A. T., Pope, C. G., Waddington, H., and Wallace, U., 1926, The antigenic value of toxoid precipitated by potassium alum, J. Pathol. Bacteriol. 29:31–40.
Gooding, D. L., Schmuck, M. N., and Gooding, K. M., 1984, Analysis of proteins with new, mildly hydrophobic high performance liquid chromatography packing materials, J. Chromatogr. 296:107–114.
Hem, S. L., and White, J. L., 1984, Characterization of aluminum hydroxide for use as an adjuvant in parenteral vaccines, J. Parenteral Sci. Tech. 38:2–10.
Hsu, P. H., 1979, Effect of phosphate and silicate on the crystallization of gibbsite from OH-A1 solutions, Soil Sci. 127:219–226.
Hsu, P. H., 1989, Aluminum hydroxides and oxyhydroxides in: Minerals in Soil Environments, 2nd ed. (J. B. Dixon and S. B. Weed, eds.), Soil Science Society of America, Madison, WI, pp. 331–378.
Imoto, T., Johnson, L. N., North, A. G, Phillips, D. C., and Rupley, J. A., 1972, Vertebrate lysozymes, in: The Enzymes, Vol. 7 (P. D. Boyer, ed.), Academic Press, New York, pp. 665–868.
Liu, J. C., Feldkamp, J. R., White, J. L., and Hem, S. L., 1984, Adsorption of phosphate by aluminum hydroxycarbonate, J. Pharm. Sci. 73:1355–1358.
MeSweeney, G. W., 1988, Fluid and electrolyte therapy and acid-base balance, in: Clinical Pharmacy and Therapeutics (E. T. Herfmdal, D. R. Gourley, and L. L. Hart, eds.), Williams & Wilkins, Baltimore, p. 2.
Masood, H., White, J. L., and Hem, S. L., 1994, Relationship between protein adsorptive capacity and the X-ray diffraction pattern of aluminum hydroxide adjuvants, Vaccine 12:187–189.
Nail, S. L., White, J. L., and Hem, S. L., 1976a, Structure of aluminum hydroxide gel I: Initial precipitate, J. Pharm. Sci. 65:1188–1191.
Nail, S. L., White, J. L., and Hem, S. L., 1976b, Structure of aluminum hydroxide gel II: Aging mechanism, J. Pharm. Sci. 65:1192–1195.
Nicklas, W., 1992, Aluminum salts, Res. Immunol. 143:489–494.
Norde, W., and Anusiem, A., 1992, Adsorption, desorption and re-adsorption of proteins on solid surfaces, Colloids Surf. 66:73–80.
Norde, W., MacRitchie, F., Nowicka, G., and Lyklema, J., 1986, Protein adsorption at solid-liquid interfaces: Reversibility and conformation aspects, J. Colloid Interface Sci. 112:447–456.
Parks, G. A., 1965, The isoelectric points of solid oxides, solid hydroxides, and aqueous hydroxo complex systems, Chem. Rev. 65:177–198.
Rinella, J. V. Jr., White, J. L., and Hem, S. L., 1995, Effect of anions on model aluminum adjuvant containing vaccines, J. Colloid Interface Sci. (in press).
Ross, S. D., 1974, Phosphates and other oxy-anions of group V, in: The Infrared Spectra of Minerals (V. C. Farmer, ed.), Mineralogical Society, London, p. 400.
Seeber, S. J., White, J. L., and Hem, S. L., 1991a, Solubilization of aluminum-containing adjuvants by constituents of interstitial fluid, J. Parenteral Sci. Tech. 45:156–159.
Seeber, S. J., White, J. L., and Hem, S. L., 1991b, Predicting the adsorption of proteins by aluminum-containing adjuvants, Vaccine 9:201–203.
Serna, C. J., White, J. L., and Hem, S. L., 1977, Anion-aluminum hydroxide gel interactions, Soil Sci. Soc. Am. 741:1009–1013.
Shirodkar, S., Hutchinson, R. L., Perry, D. L., White, J. L., and Hem, S. L., 1990, Aluminum compounds used as adjuvants in vaccines, Pharm. Res. 2:1282–1288.
Souza Santos, P., Vallejo-Friere, A., Parsons, J., and Watson, J. H. L., 1958, The structure of Schmidt’s aluminum hydroxide gel, Experientia 14:318–320.
Srinivasan, R., and Ruckenstein, E., 1980, Role of physical forces in hydrophobic interaction chromatography, Sep. Purif. Methods 9:267–370.
Tettenhorst, R., and Hofmann, D. A., 1980, Crystal chemistry of boehmite, Clays Clay Miner. 28:373–380.
Van der Marel, H. W., and Beutelspacher, H., 1976, Atlas of Infrared Spectroscopy of Clay Minerals and Their Admixtures, Elsevier, Amsterdam, pp. 194, 228.
Warren, H. S., and Chedid, L. A., 1988, Future prospects for vaccine adjuvants, CRC Crit. Rev. Immunol. 8:83–101.
Warren, H. S., Vogel, F. R., and Chedid, L. A., 1986, Current status of immunological adjuvants, Annu. Rev. Immunol. 4:369–388.
White, J. L., and Hem, S. L., 1975, Role of carbonate in aluminum hydroxide gel established by Raman and infrared analysis, J. Pharm. Sci. 64:468–469.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hem, S.L., White, J.L. (1995). Structure and Properties of Aluminum-Containing Adjuvants. In: Powell, M.F., Newman, M.J. (eds) Vaccine Design. Pharmaceutical Biotechnology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1823-5_9
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1823-5_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5737-7
Online ISBN: 978-1-4615-1823-5
eBook Packages: Springer Book Archive